Authors
Loading...
Review explores CRISPR/Cas diagnostics for early cancer detection, suggesting enhanced sensitivity and clinical applicability.
Akter et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: